¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"crossing over suppressor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carry-over effect
    ÀÜÈ¿
  • over refraction
    µ¡´ï±¼Àý°Ë»ç
  • arteriovenous crossing
    µ¿Á¤¸Æ±³Â÷
  • crossing
    1. ±³Â÷ 2. ±³¹è
  • reciprocal crossing
    ¿ª±³¹è
  • reversed crossing
    ¿ª±³Â÷
  • reversed crossing phenomenon
    ¿ª±³Â÷Çö»ó
  • extragenic suppressor mutation
    À¯ÀüÀڿܹßÇö¾ïÁ¦µ¹¿¬º¯ÀÌ
  • suppressor
    ¾ïÁ¦ÀÎÀÚ
  • suppressor area
    ¾ïÁ¦±¸¿ª
  • suppressor cell
    ¾ïÁ¦¼¼Æ÷
  • suppressor gene
    ¾ïÁ¦À¯ÀüÀÚ
  • suppressor mutation
    ¾ïÁ¦(µ¹¿¬)º¯ÀÌ
  • suppressor T cell
    ¾ïÁ¦T¼¼Æ÷
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • tumor suppressor gene
    Á¾¾ç¾ïÁ¦À¯ÀüÀÚ
  • suppressor
    ¾ïÁ¦ÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • crossing-over suppressor
    ±³Â÷¾ïÁ¦ÀÎÀÚ
  • carry-over effect
    ÀÜÈ¿
  • tie-over dressing
    ºÀÇÕ°íÁ¤µå·¹½Ì
  • nerve cross over
    ½Å°æ±³Â÷¼ú
  • over refraction
    µ¡´ï±¼Àý°Ë»ç
  • arteriovenous crossing
    µ¿Á¤¸Æ±³Â÷
  • arteriovenous crossing sign
    µ¿Á¤¸Æ±³Â÷¡ÈÄ
  • crossing
    ±³Â÷, ±³¹è
  • reciprocal crossing
    ¿ª±³¹è
  • reversed crossing
    ¿ª±³Â÷
  • reversed crossing phenomenon
    ¿ª±³Â÷Çö»ó
  • suppressor area
    ¾ïÁ¦±¸¿ª
  • suppressor cell
    ¾ïÁ¦¼¼Æ÷
  • suppressor T cell
    ¾ïÁ¦Æ¼¼¼Æ÷
  • extragenic suppressor mutation
    À¯ÀüÀڿܹßÇö¾ïÁ¦µ¹¿¬º¯ÀÌ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • OTC drug : over-the-counter drug
    ÀϹݸžà.
  • anti-idiotypic T suppressor cell
    Ç×°³º°Æ¯ÀÌÇü ¾ïÁ¦T¼¼Æ÷
  • gene, suppressor
    ¹ßÇö¾ïÁ¦À¯ÀüÀÚ
  • aortic crossing of esophagus
    ½Äµµ´ëµ¿¸Æ±³Â÷ºÎ(À§)(½Äµµ´ëµ¿¸Æ±³Â÷ºÎÀ§).
  • arteriovenous crossing
    µ¿Á¤¸Æ±³Â÷(¡­Îßó©).
  • arteriovenous crossing sign
    µ¿Á¤¸Æ±³Â÷¡ÈÄ(¡­Îßó©ó£ý¦).
  • reciprocal crossing
    »ó¹Ý±³¹è(ßÓÚãÎßÛÕ), ¿ª±³Àâ(æ½ÎßíÚ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • crossing over suppressor
    ±³Â÷¾ï¾ÐÀÎÀÚ(¡­åääâì×í­).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • crossing over
    À¯ÀüÀÚ±³È¯(ë¶îîí­Îßüµ), ±³Â÷.
  • crossing over
    À¯ÀüÀÚ±³È¯
  • crossing over
    ±³Â÷, ±³¹è.
  • aortic crossing of esophagus
    ½Äµµ´ëµ¿¸Æ±³Â÷ºÎ(À§)(½Äµµ´ëµ¿¸Æ±³Â÷ºÎÀ§).
  • arteriovenous crossing
    µ¿Á¤¸Æ±³Â÷(¡­Îßó©).
  • arteriovenous crossing sign
    µ¿Á¤¸Æ±³Â÷¡ÈÄ(¡­Îßó©ó£ý¦).
  • crossing
    ±³Â÷(Îßó©), ±³Àâ(ÎßíÚ), ±³¹è.
  • needle crossing
    ħ±³Â÷
  • reciprocal crossing
    »ó¹Ý±³¹è(ßÓÚãÎßÛÕ), ¿ª±³Àâ(æ½ÎßíÚ).
  • reversed crossing
    ¿ª±³Â÷(æ½Îßó¬) ¡ì¸Á¸·ÀÇ¡í.
  • reversed crossing phenomenon
    ¿ª±³Â÷Çö»ó(æ½Îßó¬úÞßÚ) ¸Á¸·ÀÇ .
  • bed turn over rate
    º´»óȸÀüÀ²
  • carry-over
    ÀÜÈ¿(íÑüù)
  • carry-over effect
    ÀÜÈ¿(íÑüù).
  • cross over value
    ±³Â÷°ª.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • crossing over
    "±³Â÷(Îßó©), ±³¹è(ÎßÛÕ)"
  • somatic crossing over
    ü¼¼Æ÷ ±³Â÷(ô÷á¬øàÎßó©)
  • crossing-paper electrophoresis
    "±³Â÷¿©Áö Àü±â¿µµ¿(Îß󩿤òµï³Ñ¨ç¶ÔÑ), (ÔÒ) cross-electro-phoresis"
  • intergenic suppressor mutation
    À¯ÀüÀÚ°£ ¾ï¾ÐÀÚº¯ÀÌ(ë¶îîí­Êàåääâí­Ü¨ì¶)
  • nonsense suppressor
    ³Í¼¾½º ¾ï¾ÐÀÚ(åääâí­)
  • suppressor
    "¾ï¾ÐÀÚ (åääâí­), ¾ï¾ÐÀ¯ÀüÀÚ(åääâë¶îîí­)"
  • suppressor factors
    ¾ï¾Ð(ÀÚ) ÀÎÀÚ(åääâ(í­)ì×í­)
  • suppressor gene
    ¾ï¾Ð(ÀÚ)À¯ÀüÀÚ(åääâ(í­)ë¶îîí­)
  • suppressor mutation
    ¾ï¾Ð(ÀÚ)º¯ÀÌ(åääâ(í­)ܨì¶)
  • suppressor-sensitive mutant
    ¾ï¾Ð(ÀÚ)°¨¼ö º¯ÀÌÁÖ(åääâ(í­)Êïáôܨì¶ñ»)
  • suppressor T cell
    ¾ï¾Ð(åääâ) T ¼¼Æ÷(á¬øà)
  • suppressor transfer RNA
    ¾ï¾Ð(åääâ) Àü´Þ(îîÓ¹) RNA
  • T suppressor cell
    T ¾ï¾Ð¼¼Æ÷(åääâá¬øà)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • suppressor grid
    ¾ïÁ¦°ÝÀÚ
  • over extension
    °úµµ¿¬Àå, °ú´Ù½ÅÀü
  • over-estimate
    °ú´ëÃßÁ¤
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ICC immunocompetent cells; immunocytochemistry; Indian childhood cirrhosis; intensive coronary care; int...
SCO sclerocystic ovary; somatic crossing-over; subcommissural organ
CEA Carcino-Embryonic Antigen [HP 1825-6]
  ; Oncofetal Antigens
  ; Glycopro...
OD   1) Doctor of Optometry
  2) Oculus Dexter; Right Eye; ¿ìÃø´«
  3)...
CO carbon monoxide; cardiac output; castor oil; casualty officer; centric occlusion; cervical orthosis;...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EOI Emotional Over-Involvement
NOESY Nuclear Over-hauser enhancement spectroscopy
OTC Over The Counter
ROPS Roll-over protective structures
ROT Roll-over test
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • crossing over
    ±³¹è, ±³Â÷
    Á¦ 1°¨¼öºÐ¿­ÀÇ Å»ç±â Áß¿¡ ½ÖÀ» ÀÌ·ç´Â »óµ¿ ¿°»öüÀÇ ºñÀڸŠ¿°»öºÐü »çÀÌ¿¡¼­ ÀϾ´Â À¯Àü¹°ÀÇ ±³È¯. ±× °á°ú·Î »õ·Î¿î À¯ÀüÀÚÀÇ Á¶ÇÕÀÌ ÀϾ´Ù.
  • cancer suppressor gene
    ¾Ï ¾ïÁ¦ À¯ÀüÀÚ
  • suppressor area
    ¾ïÁ¦ ¿µ¿ª
    ¿îµ¿À» ¾ïÁ¦, ¹æÇØÇÏ´Â ´ë³ú ÇÇÁúÀÇ ¿µ¿ª.
  • suppressor mutation
    ¾ïÁ¦ µ¹¿¬º¯ÀÌ
  • T-suppressor
    T ¾ï¾Ð
  • change over time
    ½Ã°£¿¡ µû¸¥ º¯È­
  • constant turn over
    ÀÏÁ¤ÇÑ È¸Àü
  • cross-over position
    ¹Ý´ëÀ§
  • over carve
    °úÀ× Á¶°¢
  • over interpretation
    °ú´Ù ÆÇµ¶
  • over work
    °ú·Î
  • slide over
    -À» ó¸®ÇÏ´Ù
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
crossing over <genetics, molecular biology> The breaking during meiosis of one maternal and one paternal chromosome, the reciprocal exchange of corresponding sections of DNA along pairs of homologous chromosomes by symmetrical breakage and crosswise rejoining of the chromosomes.
This results in the transfer of a block of genes from each chromosome to its homologue. In contrast to genetic recombination, which is a phenotypic phenomenon, crossing-over is genotypic. Any even number of crossing-overs between two loci will cancel out phenotypically and no recombination will occur.
Recombination can result from DNA exchange of alleles between between homologous chromatids in meiosis, giving rise to chiasmata.
Compare: recombination.
(10 Nov 1998)
somatic crossing-over Crossing-over that occurs during the mitosis of somatic cells, in contrast to that which occurs in meiosis.
(05 Mar 2000)
unequal crossing over <cell biology> Crossing over between homologous chromosomes that are not precisely paired, resulting in nonreciprocal exchange of material and chromosomes of unequal length. Favoured in regions containing tandemly repeated sequences.
(18 Nov 1997)
uneven crossing-over Unequal crossing-over, crossing-over that happens when the breaks do not occur at precisely homologous points in two chromatid strands, and hence results in localised duplication of genetic material in one chromatid and complementary deletion in the other.
(05 Mar 2000)
four-strand crossing over Crossing over with both strands of DNA from each sister chromatid, so that both strands from one chromatid are exchanged for both strands on the other. This is different from the usual case where only one of the two DNA strands on one sister chromatid is exchanged for the one matching strand (of the two strands) on the other sister chromatid.
(09 Oct 1997)
Gunn's crossing sign <clinical sign> Retinal arteriovenous crossing with venous compression in hypertensive disease.
(05 Mar 2000)
aged, 80 and over A person 80 years of age and older.
(12 Dec 1998)
maternal age 35 and over Pregnancy in women 35 or more years of age. It is used for normal pregnancies and for problems of pregnancy occurring in a woman's late reproductive years. These include effects on the mother's physical and mental health as well as risks of perinatal mortality and foetal abnormality.
(12 Dec 1998)
drug, over-the-counter Drug for which a prescription is not needed.
(12 Dec 1998)
tie-over dressing A dressing placed over a skin graft or other sutured wound and tied on by the sutures which have been left of sufficient length for that purpose.
Synonym: bolus dressing.
(05 Mar 2000)
flip-over disease <disease> A disease of young, fast-growing broiler chickens which causes them to die suddenly with a short, terminal, wing-beating convulsion, whereby they often flip over and die on their backs.
(05 Mar 2000)
flow-over vaporiser A device for vaporization of a liquid anaesthetic by causing gases to pass over the anaesthetic or over material saturated with the anaesthetic.
(05 Mar 2000)
amber suppressor <molecular biology> A tRNA molecule which suppresses amber mutations because it has mutated to recognise the amber codon UAG (which normally signals that the translation of mRNA into an amino acid chain should stop) as a signal for inserting whatever amino acid it carries into the chain. As a result, it can prevent the amino acid chain from ending before it is completed.
(09 Oct 1997)
genes, suppressor Genes that inhibit expression of a previous mutation. They allow the wild-type phenotype to be wholly or partially restored.
(12 Dec 1998)
genes, suppressor, tumour Genes that inhibit expression of the tumourigenic phenotype. They are normally involved in holding cellular growth in check. When tumour suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and deregulated growth is possible.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • crossing-over
    (¿°»öüÀÇ)±³Â÷
  • over and over again
    µÇÇ®ÀÌÇØ¼­
  • suppressor
    Áø¾ÐÀÚ;¾ïÁ¦ÀÚ;ÀºÆóÀÚ;±ÝÁöÀÚ
  • suppressor grid
    ¾ïÁ¦ ±×¸®µå
  • crossing
    °Ç³Î¸ñ
  • crossing
    Ⱦ´Ü;±³Â÷;µµÇ×;(µµ·ÎÀÇ)±³Â÷Á¡;(öµµÀÇ)°Ç³Î¸ñ;½ÊÀÚ·Î;Ⱦ´Üº¸µµ;±³Àâ;ÀÌÁ¾±³¹è
  • crossing guard
    (Çб³ÀÇ) °Ç³Î¸ñ ¾ÈÀü ´ç¹ø
  • crossing sweeper
    Ⱦ´Üº¸µµ û¼ÒºÎ
  • grade crossing
    (öµµ¿Í µµ·Î µîÀÇ)¼öÆò °Ç³Î¸ñ;Æò¸é ±³Â÷
  • pedestrian crossing
    Ⱦ´Ü º¸µµ
  • pelican crossing
    ´©¸§´ÜÃß ½ÅÈ£½Ä Ⱦ´Ü º¸µµ
  • railroad crossing
    öµµ °Ç³Î¸ñ )
  • railway crossing
    öµµ °Ç³Î¸ñ
  • zebra crossing
    (Èæ¹éÀÇ ¾ó·è¹«´Ì¸¦ Ä¥ÇÑ) Ⱦ´Ü º¸µµ
  • blow over
    (ÆøÇ³¿ì°¡)ÀÜÀÜÇØÁö´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á